Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | ||
Founding Date | Founding Date 2000 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | |
Employees | Employees 82517% decrease | Employees 5,669 |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 8.8 b |
Financial | ||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) ¥496.8b (FY, 2025) |
Cost of goods | Cost of goods €9.7m (FY, 2024) | Cost of goods ¥114.3b (FY, 2025) |
Gross profit | Gross profit €534.4m (FY, 2024) | Gross profit ¥383.4b (FY, 2025) |
Net income | Net income €162.2m (FY, 2024) | Net income ¥67b (FY, 2025) |
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company